SEC Filing Summary for Adicet Bio, Inc. - Officer/Director Stock Transaction

This filing details a stock option grant to Lloyd Klickstein, a director at Adicet Bio, Inc. The transaction, dated June 21, 2026, involves 4,200 stock options for Common Stock with a nominal price of $0.00. These options have an exercise price of $8.10 and are set to expire on June 20, 2036. The shares will vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon Klickstein's continued service on the board. The filing is Form 4, indicating a change in beneficial ownership.